Sitagliptin Phosphate CAS:654671-78-0 Manufacturer Supplier

Sitagliptin Phosphateest prima nova dipeptidyla peptidase IV inhibitor a Merck ad tractationem type 2 diabetarum sine lucro pondere et incidentia hypoglycemiae similis erat placebo.Sitagliptin agit augendo systema incretina corporis, quod adiuvat ut glucosem moderetur afficiendo β et α cellulas in pancreate.

Order or Request Quote

Product Detail

Product Tags

Application et effectus

Sitagliptin Phosphate trizolopyrazinum dipeptidylum peptidase IV inhibitor est.Sitagliptin nuper probatum est ad curationem diabetis speciei II. Phosphate dipeptidylo peptidase (DDP-4) inhibitor medicamentorum genus a societate Germanica Merck evolvit ac primum US cibum et medicamentum Administrationis approbationem ad tractationem generis 2 consecutus est. diabete, novum medicamentum antidiabeticum est, facultatem corporis augere potest ad gradus magnos sanguinis minuendos glucosos, et relativum incrementa naturaliter incretina occurrentia, inhibendo activitates enzyme, incluso graduum glucagono-similis peptidis 1 et insulinotropico-glucoso-dependens. peptida, ita pancreas excitat ut productionem insulinam emendare et productionem glucosi in hepate desinere, ac demum effectum clinicum defectus glucosi sanguinis minuere.

Product Sample

Product sarcina:

Additional Information:

Compositio	C16H15F6N5O.H3PO4
Assay	99%
Aspectus	Alba ad Off-White pulveris
CAS Non.	654671-78-0
stipare	25KG
Fasciae vita	Annis II
Repono	Condite in frigus et siccum area
Certification	ISO.